NCT02001480View on ClinicalTrials.gov

Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Diabetes Mellitus Type 2End Stage Renal Disease

Interventions

DEVICE

12 lead Holter

12 lead Holter measurements will be performed for 7 days

DEVICE

CGM Continuous Glucose Monitoring

CGM will be performed continously for 7 days

Trial Locations (3)

52074

Department of Internal Medicine I University Hospital RWTH Aachen, Aachen

96450

regioMed-Kliniken GmbH, Coburg

97080

University Hospital Würzburg, Würzburg

All Listed Sponsors

lead

RWTH Aachen University

OTHER

NCT02001480 - Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease | Biotech Hunter | Biotech Hunter